日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Interferon response and epigenetic modulation by SMARCA4 mutations drive ovarian tumor immunogenicity

干扰素反应和SMARCA4突变引起的表观遗传调控驱动卵巢肿瘤免疫原性

Melica Nourmoussavi Brodeur ,Higinio Dopeso ,Yingjie Zhu ,Ana Leda F Longhini ,Andrea Gazzo ,Siyu Sun ,Richard P Koche ,Rui Qu ,Laura Rosenberg ,Pierre-Jacques Hamard ,Yonina Bykov ,Hunter Green ,Laxmi Gusain ,Katherine B Chiappinelli ,Melih Arda Ozsoy ,M Herman Chui ,Thais Basili ,Rui Gardner ,Sven Walderich ,Elisa DeStanchina ,Benjamin Greenbaum ,Mithat Gönen ,Nicolas Vabret ,Britta Weigelt ,Dmitriy Zamarin

Morphologic and Molecular Heterogeneity of High-grade Serous Carcinoma Precursor Lesions

高级别浆液性癌前病变的形态学和分子异质性

Yen-Wei Chien, Yeh Wang, Peng Huang, Barrett Craig Lawson, David L Kolin, M Herman Chui, Russell Vang, Tricia A Numan, T Rinda Soong, Brant G Wang, Saron Ann Smith, Chi-Long Chen, Rebecca Stone, Christopher Douville, Tian-Li Wang, Ie-Ming Shih

Mullerian adenosarcoma: clinicopathologic and molecular characterization highlighting recurrent BAP1 loss and distinctive features of high-grade tumors

穆勒氏管腺肉瘤:临床病理学和分子特征突出复发性 BAP1 缺失和高级别肿瘤的独特特征

Amir Momeni Boroujeni, Elizabeth Kertowidjojo, Xinyu Wu, Robert A Soslow, Sarah Chiang, Edaise M Da Silva, Britta Weigelt, M Herman Chui

Genomic profiling identifies GPC5 amplification in association with sarcomatous transformation in a subset of uterine carcinosarcomas

基因组分析确定 GPC5 扩增与子宫癌肉瘤亚组中的肉瘤转化有关

M Herman Chui, Cherry Have, Lien N Hoang, Patricia Shaw, Cheng-Han Lee, Blaise A Clarke

Loss of ALDH1A1 expression is an early event in the pathogenesis of ovarian high-grade serous carcinoma

ALDH1A1表达缺失是卵巢高级别浆液性癌发病机制中的早期事件。

M Herman Chui ,Yihong Wang ,Ren-Chin Wu ,Jeffrey Seidman ,Robert J Kurman ,Tian-Li Wang ,Ie-Ming Shih